PRONULIFE®FitStay

 

Category: Healthcare–Health Food

Exhibitor: GLAC BIOTECH CO., LTD.

Booth No: J216

 

Characteristic

 

Long-term dietary habits can affect gut microbiota changes. Studies have shown that high-fat and high-sugar foods can, through the microbiota-gut-brain axis, induce inflammation in the body and affect brain function. In 1997, the World Health Organization (WHO) classified obesity as a chronic disease, and the European Commission also categorized obesity as a chronic disease in 2021.

Glac Biotech's Research and Development Center has carefully selected probiotic ingredients for blood sugar and lipid regulation, PRONULIFE®FitStay: Bifidobacterium animalis subsp. lactis CP-9 and Lactobacillus rhamnosus bv-77. The formula has been proven to reduce fat absorption in digestive tract cells, thereby reducing the formation of body fat.

【Patent】
I572713、I782550

Glac Biotech has established itself in the field of probiotics, leveraging decades of scientific research and big data platform analysis to continuously optimize probiotic manufacturing processes. By integrating modern gene chip technology, they developed the globally unique PRONEX® probiotic manufacturing technology. With world-leading probiotic production capabilities, they utilize professional expertise to extend product value and establish PRIMETEK® probiotic ODM technology.

【Read more】https://en.glac.com.tw/pronulife-fitstay-probiotics

 

Other Products

 

• 

  PRONULIFE®Effenergy

• 

  PRONULIFE®GlukoSolu

• 

  PRONULIFE®GasProtect/PRONULIFE®GasProtect-M

• 

  Brain Health Probiotics–PRONULIFE®IntBrain

• 

  PRONULIFE®IntProtect

• 

  PRONULIFE®NosRelieve/BabyAllieve

• 

  PRONULIFE®VagProtect

• 

  PRONULIFE®LvUCare

• 

  Totipro®Postbiotics PE0401/PE0301

 

 

 

Back